Treating alcohol dependence with an abuse and misuse deterrent formulation of sodium oxybate: Results of a randomised, double-blind, placebo-controlled study

Placebo—To be or not to be? Are there really alternatives to placebo-controlled trials?

(2020) Fas Jacob Krol et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Post-marketing and clinical safety experience with sodium oxybate for the treatment of alcohol withdrawal syndrome and maintenance of abstinence in alcohol-dependent subjects

(2019) Giovanni Addolorato et al.   Expert Opinion On Drug Safety

Alcohol dependence and very high risk level of alcohol consumption: a life-threatening and debilitating disease

(2018) Jürgen Rehm et al.   ADDICTION BIOLOGY

Efficacy and safety of sodium oxybate in alcohol-dependent patients with a very high drinking risk level

(2018) Wim van den Brink et al.   ADDICTION BIOLOGY

Nalmefene for the management of alcohol dependence: review on its pharmacology, mechanism of action and meta-analysis on its clinical efficacy

(2016) Karl Mann et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Sodium Oxybate in the Treatment of Alcohol Withdrawal Syndrome: A Randomized Double-Blind Comparative Study versus Oxazepam. The GATE 1 Trial

(2014) Fabio Caputo et al.   CNS DRUGS

Long-term efficacy, tolerability and safety of nalmefene as-needed in patients with alcohol dependence: A 1-year, randomised controlled study

(2014) Wim van den Brink et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Prevalence of and Potential Influencing Factors for Alcohol Dependence in Europe

(2014) Jürgen Rehm et al.   EUROPEAN ADDICTION RESEARCH

Efficacy of As-Needed Nalmefene in Alcohol-Dependent Patients with at Least a High Drinking Risk Level: Results from a Subgroup Analysis of Two Randomized Controlled 6-Month Studies

(2013) W. van den Brink et al.   ALCOHOL AND ALCOHOLISM

The Placebo Effect in Clinical Trials for Alcohol Dependence: An Exploratory Analysis of 51 Naltrexone and Acamprosate Studies

(2013) Raye Z. Litten et al.   ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH

Sodium Oxybate: A Review of Its Use in Alcohol Withdrawal Syndrome and in the Maintenance of Abstinence in Alcohol Dependence

(2013) Gillian M. Keating   CLINICAL DRUG INVESTIGATION

A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence

(2013) Antoni Gual et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Comparative abuse liability of GHB and ethanol in humans.

(2013) Matthew W. Johnson et al.   EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY

Extending the Treatment Options in Alcohol Dependence: A Randomized Controlled Study of As-Needed Nalmefene

(2012) Karl Mann et al.   BIOLOGICAL PSYCHIATRY

Baseline trajectories of heavy drinking and their effects on postrandomization drinking in the COMBINE Study: empirically derived predictors of drinking outcomes during treatment

(2011) Ralitza Gueorguieva et al.   ALCOHOL

Substitution therapy for alcoholism: time for a reappraisal?

(2011) Jonathan Chick et al.   JOURNAL OF PSYCHOPHARMACOLOGY

The relation between different dimensions of alcohol consumption and burden of disease: an overview

(2010) Jürgen Rehm et al.   ADDICTION

Baseline Trajectories of Drinking Moderate Acamprosate and Naltrexone Effects in the COMBINE Study

(2010) Ralitza Gueorguieva et al.   ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH

Behavioral effects of γ-hydroxybutyrate in humans

(2010) Alison Oliveto et al.   BEHAVIOURAL PHARMACOLOGY

Review: The involvement of gamma-hydroxybutyrate in reported sexual assaults: a systematic review

(2010) Zsófia Németh et al.   JOURNAL OF PSYCHOPHARMACOLOGY

The therapeutic potential of gamma-hydroxybutyric acid for alcohol dependence: balancing the risks and benefits. A focus on clinical data

(2009) Giovanni Addolorato et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Comparing topiramate with naltrexone in the treatment of alcohol dependence*

(2008) Danilo Antonio Baltieri et al.   ADDICTION